Biologics

Though the companies did not give any financial details, former licencing deals of Synaffix to global pharma companies such as Amgen or ranged between €400m and …

Developers of small molecule pharmaceuticals perform a battery of analytical tests before early clinical trials. These tests fulfil the regulatory requirements of the pharmacopoeia and are …

EuroBiotech_What specific expertise does Rentschler Biopharma have in the development and production of bispecific antibodies? Pollano_At Rentschler Biopharma, our strength lies in our proficiency with highly …

In contrast to classical vaccine approaches, Immunovative’s allo-priming strategy addresses the phenomenon of viral evolution. In mid-May, for the first time, the company’s CEO Michael Har-Noy …

Biotechnology production includes a broad range of various approaches to produce pharmaceuticals. Different sources for products can be used, like mammalian cell culture or microbial fermentation …

Although there is no centralised approval required for biologics from the European Medicines Agency, Germany’s Health Minister Jens Spahn has purchased 200,000 doses of the COVID-19 …

Initially, Seattle-based Just – Evotec Biologics will receive US$28.6m from the Defense Health Agency (“DHA”) under a partnership announced earlier this summer. Under the terms of …

Roche Venture Fund joined seed investor Sofinnova Partners and AbbVie Ventures and co-investors including the JDRF T1D Fund, an investor group coordinated by Banor SIM, a …

Recombinant DNA technology was initially applied in microbial hosts. The first commercial biopharmaceutical products, such as insulins, growth hormones, and interferons, were produced in bacteria or …

Apeiron Biologics announced that an expert panel has selected its clinical COVID-19 treatment APN01 to participate in the Phase II US ACTIV-4d RAAS trial, which is …